TY - JOUR
BT - European Journal of Heart Failure
PY - 2019
SP - 665 
EP -  675
T2 - European Journal of Heart Failure
TI - A trial to evaluate the effect of the sodium–glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF)
VL - 21
ER -